Microbot Begin Period Cash Flow from 2010 to 2024

MBOT Stock  USD 0.97  0.00  0.000003%   
Microbot Medical Begin Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. Begin Period Cash Flow will likely drop to about 2.4 M in 2024. Begin Period Cash Flow is the amount of cash Microbot Medical has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
1993-03-31
Previous Quarter
1.2 M
Current Value
2.5 M
Quarterly Volatility
13 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.7 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Latest Microbot Medical's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Microbot Medical over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Microbot Medical's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Pretty Stable
   Begin Period Cash Flow   
       Timeline  

Microbot Begin Period Cash Flow Regression Statistics

Arithmetic Mean12,642,762
Geometric Mean7,456,573
Coefficient Of Variation85.59
Mean Deviation8,871,436
Median10,814,000
Standard Deviation10,820,709
Sample Variance117.1T
Range32.7M
R-Value(0.11)
Mean Square Error124.5T
R-Squared0.01
Significance0.69
Slope(269,387)
Total Sum of Squares1639.2T

Microbot Begin Period Cash Flow History

20242.4 M
20232.5 M
202213.6 M
202119.7 M
202033.1 M
20195.3 M
201810.8 M

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Begin Period Cash Flow2.5 M2.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.